Eribulin 1mg Injection
Marketer
Hetero Healthcare Limited
Salt Composition
Eribulin Mesylate (1mg)
Overview Eribulin 1mg Injection
Eribulin mesylate 1mg injection is indicated for metastatic breast cancer in adults. This treatment is reserved for patients whose cancer has spread after prior anticancer therapies. Eribulin may be administered alone or in combination with other medications as determined by a physician. Intravenous administration is strictly under medical supervision; dosage and frequency are individually tailored and subject to change. Precise adherence to the prescribed regimen is crucial, as incorrect usage can lead to severe adverse reactions. While therapeutic effects might not be immediately apparent, discontinuation should only occur under medical guidance. Common side effects include fatigue, alopecia, nausea, and reduced bowel movements. Eribulin can decrease blood cell counts, increasing infection risk, necessitating regular blood tests, including monitoring of hepatic, renal, uric acid, and electrolyte levels. Peripheral neuropathy (numbness, tingling, or pins and needles) may occur; persistent symptoms require immediate medical attention. Prior to commencing treatment, disclose any pre-existing cardiovascular, hepatic, or renal conditions, or current medications, particularly anti-infectives, to your doctor. Due to potential drug interactions, full disclosure of all medications is essential. This medication is contraindicated during pregnancy and lactation; effective contraception for both partners is mandatory throughout the treatment period.
Uses of Eribulin 1mg Injection
Advanced breast cancer with distant spread
Major Benefits of Eribulin 1mg Injection:
The medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Eribulin 1mg Injection:
- Anemia (low number of red blood cells)
- Weakness
- Hair loss
- Nausea
- Constipation
- Decreased white blood cell count
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
How to use Eribulin 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Eribulin 1mg Injection works:
Eribulin, administered as a 1mg injection, is a cancer treatment that disrupts microtubule function, essential for cancer cell division. This disruption halts cancer cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption alongside Eribulin 1mg Injection is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Eribulin 1mg Injection during pregnancy poses a confirmed risk to the fetus. Nevertheless, in exceptional life-threatening circumstances, a physician might deem its use justifiable if the potential advantages outweigh the inherent dangers. Seek medical advice.
Breast feedingUNSAFE
Breastfeeding is contraindicated during treatment with Eribulin 1mg Injection due to the potential for infant toxicity.
DrivingUNSAFE
Eribulin 1mg injection can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these side effects manifest.
KidneyCAUTION
Patients with kidney impairment should receive Eribulin 1mg Injection cautiously; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should receive Eribulin 1mg Injection cautiously, potentially requiring dose modification. Physician consultation is advised.
What if you forget to take Eribulin 1mg Injection :
NA
Facts to Know About Eribulin 1mg Injection
| Label | Value |
|---|---|
| Chemical Type | Halichondrin B analog |
| Developing Good Habits | No. |
| Type of Therapy | Cancer Medications |
| Action Class | Microtubule inhibitors (excluding taxanes) |
3,018 People bought this recently